Webinar: Improved T cell function and in vivo engraftment of CAR-T cells expanded ex vivo with CTS Immune Cell SR. View now ›

CTS™ (Cell Therapy Systems) Dynabeads™ CD3/CD28

Catalog number:  40203D

 Related applications:

Cell Isolation & Expansion

| Clinical & Translational Research

Error loading your content!

  Catalog number
Select a plan
Unit size
Price ({{currency}}) Availability Qty
{{product.sku}} {{product.sku}} also known as {{product.formattedSku}} 
Pro add-ons

Your on-site stock

›› {{supplyCenter.scName}}({{scProduct.stockOnHand}} In stock)
›› {{supplyCenter.scName}}(Out of stock)
›› {{supplyCenter.scName}}
This item is not currently available on-site. Depending on your Supply Center settings you may be able to add the item to cart above else use the Order Non-Stocked Items' tab on the Supply Center home page.
Back to top


CTS™ Dynabeads™ CD3/CD28 are intended for ex vivo isolation, activation, and expansion of human T-cells in translational research. The technology—previously known as Xcyte™ Dynabeads™ or Dynabeads™ ClinExVivo™ CD3/CD28—has been used in a number of clinical studies. By combining anti-CD3 and anti-CD28 antibodies on Dynabeads, the beads provide both the primary and co-stimulatory signals that are required for activation and expansion of T cells. CTS Dynabeads CD3/CD28 are manufactured and controlled according to ISO 9001:2000 and ISO 13485:2012 requirements. A Device Master File is held with the FDA for cross-referencing in IND applications, and a CoA is available on request. In the US, CTS Dynabeads CD3/CD28 are available for clinical use only under an approved Investigational New Drug (IND) application. Dynabeads™ Human T-Expander CD3/CD28 (Cat. No. 11141D) is the research grade version of CTS Dynabeads CD3/CD28, containing the same amount and ratio of antibodies from the same clones as CTS Dynabeads CD3/CD28, and intended for small scale pre-clinical research.

The CTS Dynabeads CD3/CD28 technology has been successfully used in ex vivo isolation, activation, and expansion of T-cells in a number of studies, including studies on HIV infection and cancer. Other potential applications for this novel technology include research into treatment of autoimmune and infectious diseases and prevention of complications associated with chemotherapy and allogeneic stem cell transplantation.

For research use or non-commercial manufacturing of cell-based products for clinical research. CAUTION: Not intended for direct administration into humans or animals.


Cell Type: T Cells (Whole Population)
Clonality: Monoclonal
Final Product: Cells
Product Line: CTS™, DYNAL®, Dynabeads®
Product Size: 10 mL
Reactivity: Human
Sample Type (Specific): Cell Cultures, Clinical Sample, PBMC
Target Species: Human
Shipping Condition: Wet Ice

Contents & storage

The product contains: CTS Dynabeads CD3/CD28 supplied as a sterile, non-pyrogenic suspension containing 4 x 108 Dynabeads/mL in phosphate buffered saline (PBS), pH 7.4, with 0.1% recombinant human serum albumin (rHSA).

Store at: 2-8°C.


Manuals & protocols